P9WGI5
Gene name |
sigB (mysB, Rv2710) |
Protein name |
RNA polymerase sigma factor SigB |
Names |
|
Species |
Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) |
KEGG Pathway |
mtu:Rv2710 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
5 structures for P9WGI5
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| 7PP4 | EM | 384 A | f | 1-323 | PDB |
| 7Q4U | EM | 439 A | EA/F/KA/L/QA/R/WA/Y | 1-323 | PDB |
| 7Q59 | EM | 436 A | F/f | 1-323 | PDB |
| 7ZF2 | EM | 386 A | F | 1-323 | PDB |
| AF-P9WGI5-F1 | Predicted | AlphaFoldDB |
No variants for P9WGI5
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for P9WGI5 | |||||
No associated diseases with P9WGI5
10 regional properties for P9WGI5
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | RNA polymerase sigma-70 | 156 - 169 | IPR000943-1 |
| domain | RNA polymerase sigma-70 | 180 - 188 | IPR000943-2 |
| domain | RNA polymerase sigma-70 | 304 - 316 | IPR000943-3 |
| domain | RNA polymerase sigma-70 | 325 - 351 | IPR000943-4 |
| domain | RNA polymerase sigma-70 region 3 | 211 - 287 | IPR007624 |
| domain | RNA polymerase sigma-70 region 2 | 132 - 201 | IPR007627 |
| domain | RNA polymerase sigma-70 region 4 | 300 - 353 | IPR007630 |
| domain | RNA polymerase sigma-70 region 1.2 | 91 - 123 | IPR009042 |
| domain | RNA polymerase sigma factor RpoD, C-terminal | 128 - 364 | IPR012760 |
| domain | RNA polymerase sigma-70 like domain | 130 - 353 | IPR014284 |
2 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
3 GO annotations of molecular function
| Name | Definition |
|---|---|
| DNA binding | Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
| RNA polymerase core enzyme binding | Binding to an RNA polymerase core enzyme, containing a specific subunit composition defined as the core enzyme. |
| sigma factor activity | Sigma factors act as the promoter specificity subunit of eubacterial and plant plastid multisubunit RNA polymerases, whose core subunit composition is often described as alpha(2)-beta-beta-prime. Although sigma does not bind DNA on its own, when combined with the core to form the holoenzyme, the sigma factor binds specifically to promoter elements. The sigma subunit is released once elongation begins. |
5 GO annotations of biological process
| Name | Definition |
|---|---|
| DNA-templated transcription initiation | The initial step of transcription, consisting of the assembly of the RNA polymerase preinitiation complex (PIC) at a gene promoter, as well as the formation of the first few bonds of the RNA transcript. Transcription initiation includes abortive initiation events, which occur when the first few nucleotides are repeatedly synthesized and then released, and ends when promoter clearance takes place. |
| positive regulation of DNA-templated transcription | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
| response to heat | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism. |
| response to hypoxia | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. |
| response to xenobiotic stimulus | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a xenobiotic, a compound foreign to the organim exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MADAPTRATT | SRVDSDLDAQ | SPAADLVRVY | LNGIGKTALL | NAAGEVELAK | RIEAGLYAEH |
| 70 | 80 | 90 | 100 | 110 | 120 |
| LLETRKRLGE | NRKRDLAAVV | RDGEAARRHL | LEANLRLVVS | LAKRYTGRGM | PLLDLIQEGN |
| 130 | 140 | 150 | 160 | 170 | 180 |
| LGLIRAMEKF | DYTKGFKFST | YATWWIRQAI | TRGMADQSRT | IRLPVHLVEQ | VNKLARIKRE |
| 190 | 200 | 210 | 220 | 230 | 240 |
| MHQHLGREAT | DEELAAESGI | PIDKINDLLE | HSRDPVSLDM | PVGSEEEAPL | GDFIEDAEAM |
| 250 | 260 | 270 | 280 | 290 | 300 |
| SAENAVIAEL | LHTDIRSVLA | TLDEREHQVI | RLRFGLDDGQ | PRTLDQIGKL | FGLSRERVRQ |
| 310 | 320 | ||||
| IERDVMSKLR | HGERADRLRS | YAS |